[Clinical application of enzyme inhibitor in bronchial asthma and respiratory tract infection].
Yamada
G
G
Makino
S
S
D000818:Animals; D017302:Annexins; D001249:Asthma / Q000188:drug therapy*; D002135:Calcium-Binding Proteins / Q000494:pharmacology / Q000627:therapeutic use; D004205:Cromolyn Sodium / Q000627:therapeutic use; D006801:Humans; D016859:Lipoxygenase Inhibitors / Q000627:therapeutic use*; D008689:Methacrylates / Q000494:pharmacology / Q000627:therapeutic use; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D010741:Phospholipases A / Q000037:antagonists & inhibitors; D010793:Phthalazines / Q000627:therapeutic use; D011480:Protease Inhibitors / Q000627:therapeutic use; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors
D017302:Annexins; D002135:Calcium-Binding Proteins; D016859:Lipoxygenase Inhibitors; D008689:Methacrylates; D010726:Phosphodiesterase Inhibitors; D010793:Phthalazines; D011480:Protease Inhibitors; D010741:Phospholipases A; D013930:Thromboxane-A Synthase; C034364:ozagrel; D004205:Cromolyn Sodium; C020976:azelastine